| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.40B | 25.89B | 26.47B | 25.45B | 24.15B | 22.80B |
| Gross Profit | 6.86B | 6.92B | 7.18B | 6.68B | 7.12B | 6.00B |
| EBITDA | 1.63B | 1.68B | 2.16B | 2.03B | 2.94B | 1.56B |
| Net Income | 505.13M | 543.83M | 969.86M | 870.02M | 1.61B | 632.41M |
Balance Sheet | ||||||
| Total Assets | 23.80B | 25.47B | 26.43B | 25.49B | 23.67B | 23.61B |
| Cash, Cash Equivalents and Short-Term Investments | 4.08B | 5.12B | 5.35B | 4.63B | 5.17B | 4.55B |
| Total Debt | 4.86B | 5.50B | 6.07B | 5.92B | 4.71B | 5.58B |
| Total Liabilities | 13.04B | 14.25B | 15.41B | 15.07B | 13.71B | 14.81B |
| Stockholders Equity | 10.73B | 11.20B | 10.98B | 10.39B | 9.91B | 8.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 951.15M | 964.78M | -1.59B | 1.66B | 1.56B |
| Operating Cash Flow | 0.00 | 1.71B | 2.11B | -637.94M | 2.31B | 2.13B |
| Investing Cash Flow | 0.00 | -897.87M | -1.15B | -656.17M | -367.19M | -654.52M |
| Financing Cash Flow | 0.00 | -1.04B | -254.05M | 749.14M | -1.25B | -347.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥7.96B | 9.70 | ― | 2.89% | 3.52% | 42.80% | |
72 Outperform | ¥10.05B | 19.87 | ― | 3.74% | -29.79% | 278.17% | |
71 Outperform | ¥8.77B | -13.90 | ― | 4.38% | -16.09% | -163.96% | |
70 Outperform | ¥7.25B | 17.40 | ― | 3.77% | 11.25% | 26.01% | |
70 Outperform | ¥8.30B | 16.96 | ― | 2.03% | 16.10% | -10.63% | |
69 Neutral | ¥8.97B | 40.25 | ― | 4.94% | -4.23% | -64.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |